Neovasc IncTSX:NVCNView on NASDAQ
- LAST PRICE37.0900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 37.0900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVCN |
|---|---|---|
| 10:29 ET | 200 | 37 |
| 10:51 ET | 100 | 36.93 |
| 12:17 ET | 200 | 36.97 |
| 02:14 ET | 100 | 37.1 |
| 03:30 ET | 300 | 37.09 |
| 03:32 ET | 100 | 37.09 |
| 03:42 ET | 500 | 37.09 |
| 03:46 ET | 100 | 37.09 |
| 03:53 ET | 1000 | 37.09 |
| 03:55 ET | 1000 | 37.09 |
Jan 21, 2023
Moore Kuehn Encourages NVCN, VLTA, CNCE, and ANGN Investors to Contact Law Firm, from 11:46PM ET on Saturday Jan 21, 2023 by PR Newswire
11:46PM ET on Saturday Jan 21, 2023 by PR Newswire
Jan 18, 2023
--HC Wainwright Downgrades Neovasc to Neutral From Buy, from 7:53AM ET on Wednesday Jan 18, 2023 by MT Newswires
7:53AM ET on Wednesday Jan 18, 2023 by MT Newswires
Jan 17, 2023
Top Midday Gainers, from 1:45PM ET on Tuesday Jan 17, 2023 by MT Newswires
1:45PM ET on Tuesday Jan 17, 2023 by MT NewswiresSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Neovasc Inc. (NVCN), from 11:21AM ET on Tuesday Jan 17, 2023 by Newsfile
11:21AM ET on Tuesday Jan 17, 2023 by NewsfileCANADA STOCKS-TSX hits one-month high as domestic inflation eases, from 11:02AM ET on Tuesday Jan 17, 2023 by Thomson Reuters
11:02AM ET on Tuesday Jan 17, 2023 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neovasc Inc | 102.1M | -2.3x | --- |
Perimeter Medical Imaging AI Inc | 106.4M | -6.6x | --- |
MedMira Inc | 87.6M | -43.6x | --- |
Theralase Technologies Inc | 75.8M | -12.7x | --- |
Cannabix Technologies Inc | 48.5M | -14.5x | --- |
Vitalhub Corp | 116.5M | 120.0x | --- |
Company Information
Neovasc Inc. is a Canada-based specialty medical device company. The Company develops, manufactures, and markets products for the cardiovascular marketplace. The Company is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. The Company's products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle; and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel, and Europe. The Company operates through the development, manufacturing, and marketing of medical devices segment. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.
Contact Information
- Headquarters
- Richmond, 5138-13562 Maycrest WayRICHMOND, BC, Canada V6V 2J7
- Phone
- 604-270-4344
- Fax
- 604-270-4344
Executives
- Independent Chairman of the Board
- Steven Rubin
- President, Chief Executive Officer, Director
- Fred Colen
- Chief Financial Officer, Corporate Secretary
- Christopher Clark
- Chief Operating Officer
- Bill Little
- Vice President - Regulatory Affairs, Global Angina Therapies
- Lisa Becker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $102.7M |
|---|---|
Revenue (TTM) | $4.2M |
Shares Outstanding | 2.8M |
Neovasc Inc does not pay a dividend. | |
Beta | 2.18 |
EPS | $-16.47 |
Book Value | $25.83 |
P/E Ratio | -2.3x |
Price/Sales (TTM) | 24.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -857.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
